Seqster is a health data management platform that enables individuals to aggregate, integrate, and manage their health data from various sources.

Seqster

SEQSTER is the leading healthcare technology company that breaks down health data silos at scale. Its enterprise operating system aggregates disparate health data sources into a single, 360-degree view of a patient in real-time, solving a multitude of challenges for life sciences, patient engagement and data interoperability.

SEQSTER has nationwide coverage of EHRs from hospitals and medical groups, genomic DNA, wearables, pharmacy and social determinants of health data. Through its customizable white-label approach, Seqster provides accelerated access to de-identified, tokenized, real-time data and comprehensive curated data to address critical needs across the healthcare continuum.

SEQSTER is privately held and headquartered in San Diego. To learn more about SEQSTER's Operating System for Patient-Centric Real World Data, please contact us at info@seqster.com or visit www.seqster.com.

SEQSTER

Going to #SCOPESummit ? 

Schedule time with our team to see how 1-Click Records™ for Clinical Trials works👇: 

Pick a time here 👉: https://shorturl.at/lJSU2

Retrieve a Patient’s Longitudinal Health Record In Seconds.

✅  Access to ► 300M+ Medical Records
✅  Instantly Retrieve Real World Data
✅  Populate Retrospective ► Prospective Data
✅  Save Time & Costs Obtaining High-Quality Data

#DigitalHealth
#1ClickRecords
#SeqsterOS
#MedicalRecords
#ClinicalTrials


It’s only 16 days into 2024…

Team SEQSTER is on 🔥 with #innovation and #execution for #healthcare & #lifesciences !

“Integrating the SEQSTER Admin Portal into our pre-screening workflow significantly expedites the acquisition of medical records, crucial for determining eligibility in the trial and capturing baseline eCRF data. The collaboration between UBC and SEQSTER empowers us to introduce modernized study designs to sponsors. These innovative approaches leverage the patient's ability to take control of their medical records, breathing life into studies that transcend traditional models relying solely on healthcare providers for furnishing patient information,” said Aaron Berger  SVP of Evidence Development Solutions at UBC 


https://lnkd.in/gSxvu3U9

New year, same thrilling mission! Team SEQSTER is revved up and ready to rocket #RealWorldData to new heights, bringing groundbreaking insights to life for patients & researchers. 

Happy New Year ! 💚🚀

#ICYMI 👇 

Atropos Health and SEQSTER have partnered to simplify the establishment of patient registries and enhance the availability of real-world evidence (#RWE), accelerating evidence generation and driving advancements in research for underserved populations.

Congratulations to our CEO & Co-Founder ⬥ Ardy Arianpour ⬥ & Atropos Health CEO & Co-Founder Brigham Hyde on this vision and execution!

#DigitalHealth
#SeqsterOS
#RealWorldEvidence
#RealWorldData


https://lnkd.in/gKUSESDY

Welcome to the forefront of healthcare #innovation! SEQSTER and Atropos Health have joined forces with a common goal: to address the pressing challenges of diversity and inclusion in clinical trials. 

With our pioneering partnership, we establish turnkey patient registries in less than 48 hours ⏱️ Real World Evidence is now possible through Generative AI🤖

If you're interested in using patient registries to accelerate #clinicaltrials and enhance patient care, reach out to us today! Let us help you unlock the potential of real-world evidence and drive innovation at your organization.

Check out the latest Press from MedCity News below! 

#DigitalHealth
#SeqsterOS
#RegulatoryGradeData
#GenerativeAi
#RWD
#RWE
https://lnkd.in/gCuhU5V7

Metric
Company Name	Seqster
Symbol
MSH ID	COM:SEQSTER
Market	PRIVATE
Sector	Technology
Industry	Healthcare Technology
Country	US
Stage
Employee Count	14
Website	seqster.com
LinkedIn	seqster
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

COM:SEQSTER

Seqster

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue